KREITZER ANATOL (Chief Discovery Officer) received a stock award from MAPLIGHT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/9/2026ACC: 0002021238-26-000004
Officer· Chief Discovery Officer
Since Feb 2026
+30.48K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
30.48K acquired
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
+6.02K
Price / share
—
Trade value
—
% of position
2.4%
2/5/2026
253.91K→259.93K
Total
Net shares
+6.02K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 2/5/2026 | A · Award | +6.02K | — | — | 2.4% | 253.91K | 259.93K |
| Total | +6.02K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Voting Common Stock
24.45K shares
Shares
+24.45K
Strike price
15.70
Held after
24.45K
Exercisable
—
2/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Voting Common Stock24.45K shares | 2/5/2026 | A · Award | +24.45K | 15.70 | — | 24.45K |